Hyderabad, May 29, 2026: Envision Lasik Centre, led by renowned ophthalmologist Dr. Advaith Sai Alampur, has become the second clinic in South India to introduce Envision by InMode — an advanced, non-surgical technology designed to address dry eye disease at its root cause while simultaneously improving periorbital aesthetic concerns.
Dry eye disease is one of the most prevalent yet underdiagnosed eye conditions in India, driven by excessive screen exposure, pollution, environmental stress, and modern lifestyle habits. While conventional eye drops offer only temporary relief, Envision by InMode delivers a more comprehensive and long-term solution by restoring natural tear function and reducing inflammation.
What Makes Envision Different
- Treats the Root Cause: Powered by Forma-I, the treatment helps unblock meibomian glands and restore healthy tear production.
- Targets Inflammation: Powered by Lumecca-I, one of the world’s leading IPL technologies, it effectively reduces eyelid inflammation associated with dry eye disease.
- Long-Lasting Relief: Goes beyond symptom management to improve overall ocular surface health.
- Quick & Comfortable: Non-invasive 10–12 minute sessions with no downtime.
- Safe & Clinically Proven: Backed by global clinical success and patient outcomes.
A Global Legacy in Eye & Aesthetic Innovation
InMode, a global leader in minimally invasive medical technologies, is internationally recognized for pioneering advanced solutions in ocular and aesthetic care. Its portfolio includes technologies such as Forma-I and Lumecca-I for eye and skin health, as well as Morpheus8, the globally acclaimed fractional RF micro needling treatment known for addressing under-eye bags, droopy eyelids, skin tightening, and advanced rejuvenation
